Phase I trial of dihydrolenperone in lung cancer patients: A novel compound with in vitro activity against lung cancer

Bruce E. Johnson, Robert Parker, C. M. Tsai, Julie Baltz, Mae Jean Miller, Robert Shoemaker, Ruby Phelps, Anne Bastian, Joyce Stocker, John Phares, James L. Mulshine, Adi F. Gazdar, Daniel C. Ihde

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of dihydrolenperone in lung cancer patients: A novel compound with in vitro activity against lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences